Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Complications

Variations in Adiponectin Receptor Genes and Susceptibility to Type 2 Diabetes in Women

A Tagging–Single Nucleotide Polymorphism Haplotype Analysis

  1. Lu Qi12,
  2. Alessandro Doria3,
  3. Elena Giorgi4 and
  4. Frank B. Hu135
  1. 1Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts
  2. 2Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
  3. 3Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts
  4. 4Department of Mathematics and Statistics, University of Massachusetts, Amherst, Massachusetts
  5. 5Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
  1. Address correspondence and reprint requests to Dr. Lu Qi, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115. E-mail: nhlqi{at}channing.harvard.edu
Diabetes 2007 Jun; 56(6): 1586-1591. https://doi.org/10.2337/db06-1447
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Pairwise LD matrix for ADIPOR1 (A) and ADIPOR2 (B) genes. D′ is presented above the diagonal, and r2 is presented below the diagonal.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Haplotype cladogram for the ADIPOR1 gene. Gray circles represent the inferred haplotypes with their frequencies, which are proportional to the size (diameter) of the circles. P1–P6 represent the polymorphic changes (in the order of rs2232853, rs10494839, rs12733285, rs1342387, rs1139646, and rs10920531) separating one haplotype from the other.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Sliding window analyses of the associations between ADIPOR2 haplotypes (possessing two to six SNPs) and the risk of type 2 diabetes. −log10 P values of global tests for the haplotype windows are presented as solid diamonds. The haplotype windows for a given number of SNPs (two to six) were generated by grouping the corresponding number of SNPs in the order of the position of polymorphisms and moving one SNP each time from 5′ to 3′ end.

Tables

  • Figures
  • TABLE 1

    Polymorphisms in ADIPOR1 and ADIPOR2 genes

    PolymorphismsAllelePositionLocationMAF
    ADIPOR1
        rs2232853G>A−117605′ promoter0.28
        rs10494839T>C−1896Intron 10.28
        rs12733285C>T−1742Intron 10.31
        rs1342387C>T5843Intron 40.46
        rs1139646*C>G10225Exon 8–3′ UTR0.32
        rs10920531C>A113633′ UTR0.37
    ADIPOR2
        rs11061925C>T−60276Intron 10.29
        rs7132033G>C−57414Intron 10.27
        rs7975600T>A−48258Intron 10.13
        rs11061937T>C−46897Intron 10.30
        rs12826079C>T−36954Intron 10.07
        rs11061946G>A−34983Intron 10.07
        rs10773983C>T−32264Intron 10.32
        rs11612383C>T−32155Intron 10.32
        rs1058322C>T−26531Intron 10.31
        rs12230440T>G−6557Intron 10.15
        rs929434G>A−1421Intron 10.30
        rs11061971A>T218Intron 20.44
        rs11061973G>A2426Intron 20.14
        rs2108642C>A3289Intron 20.46
        rs7316374G>A7621Intron 20.14
        rs1044471C>T334463′ UTR0.48
    • Alleles are presented as common allele>minor allele. Location of polymorphism is relative to the translation start point.

    • *

      * rs1139646 is also known as rs7539542.

  • TABLE 2

    Genotype distributions of polymorphism in ADIPOR1 and ADIPOR2 genes in diabetic case and control subjects

    PolymorphismsCase (%)/control (%) by genotype
    Odds ratio (95% CI)
    Homozygote, majorHeterozygoteHomozygote, minorCrudeAdjusted*
    ADIPOR1
        rs2232853341 (49.1)/565 (51.4)297 (42.7)/440 (40.0)57 (8.2)/94 (8.6)1.10 (0.91–1.33)1.16 (0.94–1.43)
        rs10494839340 (48.7)/557 (51.1)296 (42.4)/438 (40.2)62 (8.9)/95 (8.7)1.11 (0.91–1.34)1.17 (0.95–1.44)
        rs12733285344 (49.4)/511 (47.1)293 (42.0)/485 (44.7)60 (8.6)/88 (8.2)0.91 (0.75–1.10)0.87 (0.70–1.07)
        rs1342387210 (30.4)/297 (27.8)347 (50.4)/558 (52.3)132 (19.2)/212 (19.9)0.88 (0.71–1.09)0.77 (0.61–0.98)
        rs1139646290 (43.2)/513 (48.7)306 (45.5)/433 (41.1)76 (11.3)/108 (10.2)1.26 (1.03–1.53)1.36 (1.10–1.70)
        rs10920531266 (37.9)/464 (42.6)329 (46.9)/470 (43.1)107 (15.2)/156 (14.3)1.21 (1.00–1.47)1.33 (1.08–1.65)
    ADIPOR2
        rs11061925336 (48.4)/552 (50.7)301 (43.3)/429 (39.4)58 (8.3)/108 (9.9)1.10 (0.90–1.32)1.22 (0.99–1.51)
        rs7132033363 (51.5)/587 (53.2)292 (41.4)/419 (37.9)50 (7.1)/98 (8.9)1.07 (0.88–1.29)1.18 (0.96–1.46)
        rs7975600521 (75.7)/814 (75.7)156 (22.7)/236 (22.0)11 (1.6)/25 (2.3)1.00 (0.80–1.25)1.02 (0.80–1.31)
        rs11061937334 (48.0)/518 (48.1)296 (42.5)/444 (41.3)66 (9.5)/114 (10.6)1.01 (0.83–1.22)1.12 (0.90–1.38)
        rs12826079617 (87.6)/959 (86.7)85 (12.1)/143 (12.9)2 (0.3)/4 (0.4)0.92 (0.69–1.22)1.01 (0.74–1.38)
        rs11061946594 (84.4)/941 (85.0)104 (14.8)/160 (14.5)6 (0.8)/6 (0.5)1.05 (0.81–1.36)1.08 (0.81–1.44)
        rs10773983306 (44.5)/492 (45.5)317 (46.1)/464 (42.9)65 (9.4)/125 (11.6)1.04 (0.86–1.26)1.05 (0.85–1.30)
        rs11612383335 (47.6)/496 (45.9)297 (42.2)/475 (44.0)72 (10.2)/109 (10)0.93 (0.77–1.13)0.98 (0.80–1.21)
        rs1058322323 (46.6)/514 (48.0)300 (43.3)/448 (41.8)70 (10.1)/109 (10.2)1.06 (0.87–1.28)1.12 (0.91–1.38)
        rs12230440476 (70.7)/745 (70.8)184 (27.4)/288 (27.4)13 (1.9)/19 (1.8)1.00 (0.81–1.24)1.10 (0.87–1.39)
        rs929434321 (47.2)/496 (47.6)295 (43.3)/435 (41.8)65 (9.5)/110 (10.6)1.02 (0.84–1.24)1.13 (0.91–1.40)
        rs11061971216 (31.4)/335 (31.2)337 (49.0)/510 (47.6)135 (19.6)/227 (21.2)0.99 (0.80–1.22)1.09 (0.86–1.37)
        rs11061973501 (72.7)/783 (72.1)173 (25.1)/284 (26.1)15 (2.2)/19 (1.8)0.97 (0.78–1.20)1.02 (0.80–1.28)
        rs2108642195 (28.1)/313 (28.8)343 (49.4)/516 (47.4)156 (22.5)/259 (23.8)1.03 (0.84–1.28)1.16 (0.92–1.46)
        rs7316374542 (76.6)/818 (74.1)156 (22.0)/267 (24.2)10 (1.4)/19 (1.7)0.88 (0.70–1.09)0.89 (0.70–1.13)
        rs1044471185 (27.3)/319 (29.6)329 (48.4)/514 (47.8)165 (24.3)/243 (22.6)1.12 (0.91–1.39)1.11 (0.87–1.40)
    • rs1139646 is also known as rs7539542.

    • *

      * Adjusted for age, BMI, alcohol consumption, smoking, physical activity, family history of diabetes, and menopausal status—under dominant inheritance mode.

  • TABLE 3

    Distributions of haplotypes* inferred from ADIPOR1 polymorphisms in diabetic case and control subjects

    rs2232853rs10494839rs12733285rs1342387rs1139646rs10920531Frequency
    OR (95% CI)†P
    CasesControls
    1100000.2550.2431.0—
    0011000.1880.2080.76 (0.61–0.96)0.02
    0000110.2060.1891.00 (0.80–1.23)0.94
    0001000.1130.1200.85 (0.66–1.10)0.22
    0011110.0800.0631.28 (0.93–1.75)0.13
    Haplotypes <5%0.1570.1760.78 (0.61–0.98)0.03
    • Global test: −2log-likehood = 15.1 on 5 df, P = 0.0098.

    • *

      * 0 codes the common allele, and 1 codes the minor allele.

    • †

      † Adjusted for age, BMI, alcohol consumption, smoking, physical activity, and menopausal status.

PreviousNext
Back to top

In this Issue

June 2007, 56(6)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variations in Adiponectin Receptor Genes and Susceptibility to Type 2 Diabetes in Women
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Variations in Adiponectin Receptor Genes and Susceptibility to Type 2 Diabetes in Women
Lu Qi, Alessandro Doria, Elena Giorgi, Frank B. Hu
Diabetes Jun 2007, 56 (6) 1586-1591; DOI: 10.2337/db06-1447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Variations in Adiponectin Receptor Genes and Susceptibility to Type 2 Diabetes in Women
Lu Qi, Alessandro Doria, Elena Giorgi, Frank B. Hu
Diabetes Jun 2007, 56 (6) 1586-1591; DOI: 10.2337/db06-1447
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy
  • CaM Kinase II-δ Is Required for Diabetic Hyperglycemia and Retinopathy but Not Nephropathy
  • Connectivity Mapping Identifies BI-2536 as a Potential Drug to Treat Diabetic Kidney Disease
Show more Complications

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.